Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAston Martin Lagonda Regulatory News (AML)

Share Price Information for Aston Martin Lagonda (AML)

Share Price is delayed by 15 minutes
Get Live Data
41.12    -1.44 (-3.38%)
Bid:
41.06
Ask:
43.48
Spread: 2.42 (5.894%)
Market Cap: £416.42m
AML Live PriceLast checked at - London Stock Exchange

Intraday Aston Martin Lagonda Share Chart

Director Declaration

20 Apr 2022 12:19

RNS Number : 7764I
Aston Martin Lagonda Global Hld PLC
20 April 2022
 

20 April 2022

 

 

 

Aston Martin Lagonda Global Holdings plc

Director Declaration

 

Aston Martin Lagonda Global Holdings plc (the "Company") announces in accordance with Listing Rule 9.6.14R that Dr Anne Stevens Non-Executive Director and Chair of the Remuneration and Sustainability Committees, has been appointed as a non-executive director of AVEVA Group plc ("AVEVA") with effect from 1 May 2022. Anne will also serve on the Remuneration and Audit Committees of AVEVA and following the conclusion of its 2022 Annual General Meeting, Anne will become the Chair of its Remuneration Committee.

 

 

 

 

 

 

 

Enquiries

 

Investors and Analysts

Charlotte Cowley,

Director of Investor Relations

 

 

+44 (0)7771 976764

charlotte.cowley@astonmartin.com

Holly Grainger

Deputy Head Investor Relations

 

+44 (0)7442 989551

holly.grainger@astonmartin.com

Brandon Henderson

Senior Manager, Investor Relations

 

 

+44 (0)7585326704

brandon.henderson@astonmartin.com

Media

Kevin Watters,

Director of Communications 

 

+44 (0)7764 386683

kevin.watters@astonmartin.com

Paul Garbett

Head of Corporate Brand Communications

 

+44 (0)7501 380799

paul.garbett@astonmartin.com

Grace Barnie,

Corporate Communications Manager

 

 +44 (0)7880 903490

grace.barnie@astonmartin.com

Tulchan Communications

Harry Cameron and Simon Pilkington 

 

+44 (0)20 73534200

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNIMMBTMTBTBRT
Date   Source Headline
22nd Apr 20204:35 pmRNSPrice Monitoring Extension
21st Apr 20209:00 amRNSHolding(s) in Company
21st Apr 20209:00 amRNSHolding(s) in Company
21st Apr 20209:00 amRNSHolding(s) in Company
20th Apr 20209:18 amRNSAnnouncement re: Rights Issue
20th Apr 20207:05 amRNSStatement from Executive Chairman, Lawrence Stroll
20th Apr 20207:00 amRNSAnnouncement re: Rights Issue
17th Apr 20202:25 pmRNSHolding(s) in Company
17th Apr 20202:17 pmRNSHolding(s) in Company
17th Apr 20202:14 pmRNSHolding(s) in Company
17th Apr 20202:12 pmRNSHolding(s) in Company
8th Apr 20204:36 pmRNSPrice Monitoring Extension
8th Apr 202010:00 amRNSHolding(s) in Company
8th Apr 20209:00 amRNSAston Martin announces Interim CFO appointment
3rd Apr 20208:15 amRNSSuccessful private placement of nil paid rights
1st Apr 20203:45 pmRNSHolding(s) in Company
1st Apr 20203:45 pmRNSHolding(s) in Company
1st Apr 20203:10 pmRNSHolding(s) in Company
1st Apr 20207:00 amRNSAdditional Listing
31st Mar 20207:00 amRNSAdditional Listing
30th Mar 20205:21 pmRNSAnnouncement re: Rights Issue
30th Mar 20205:19 pmRNSResult of Meeting
24th Mar 20201:05 pmRNSUpdate on operations and the impact of COVID-19
17th Mar 20204:40 pmRNSSecond Price Monitoring Extn
17th Mar 20204:35 pmRNSPrice Monitoring Extension
17th Mar 20202:40 pmRNSAnnual Financial Report
13th Mar 20204:36 pmRNSAnnouncement re: Rights Issue
12th Mar 20204:45 pmRNSSecond Price Monitoring Extn
12th Mar 20204:40 pmRNSPrice Monitoring Extension
28th Feb 202010:00 amRNSTotal Voting Rights
27th Feb 20202:31 pmRNSPublication of a Prospectus
27th Feb 20207:00 amRNSAnnouncement re: Rights Issue
27th Feb 20207:00 amRNSDirectorate Change
27th Feb 20207:00 amRNSFinal Results
21st Feb 202011:49 amRNSHolding(s) in Company
21st Feb 202011:31 amRNSHolding(s) in Company
17th Feb 202011:28 amRNSHolding(s) in Company
17th Feb 202011:26 amRNSHolding(s) in Company
17th Feb 202011:22 amRNSHolding(s) in Company
17th Feb 202011:18 amRNSHolding(s) in Company
14th Feb 20203:26 pmRNSDirector/PDMR Shareholding
11th Feb 20203:12 pmRNSDirector/PDMR Shareholding
11th Feb 20203:11 pmRNSHolding(s) in Company
11th Feb 20203:09 pmRNSHolding(s) in Company
11th Feb 20203:05 pmRNSHolding(s) in Company
10th Feb 20204:07 pmRNSPassing Away of Non-Executive Director
31st Jan 20207:00 amRNSIssue of Equity
30th Jan 202010:52 amRNSTotal Voting Rights
7th Jan 20206:01 pmRNSTrading Statement - Clarification
7th Jan 20207:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.